Real problems worth solving

A survey of 166 emergency physicians found that 74.1% reported their departments had no policy or procedure for communicating with deaf patients. 88% of these physicians had never attended any training on deaf patient communication, despite 83.7% believing such training should be available. A separate 2025 mixed-methods study found that 65% of deaf and hard-of-hearing patients reported difficulties communicating with ER staff, and only 28.8% could independently communicate with ER staff at all. This matters because the emergency department is where communication failures have the highest stakes. A deaf patient arriving with chest pain, a stroke, or an allergic reaction cannot explain their symptoms, medication allergies, or medical history via a notepad in a high-stress, time-pressured environment. The most common communication method offered was a family member acting as interpreter (63.9%) or writing on paper (16.9%). Family interpreters are ethically problematic — patients may not disclose domestic abuse, substance use, or sexual health issues through a relative — and medically dangerous, since family members lack medical vocabulary and may mistranslate critical information. The result is misdiagnosis, wrong medications, delayed treatment, and preventable harm. The structural reason this persists is that the ADA requires 'effective communication' but does not specify exactly how hospitals must achieve it, leaving enforcement reactive (complaints and lawsuits after harm occurs). Video Remote Interpreting (VRI) technology exists and could provide an ASL interpreter within minutes via tablet, but many hospitals either have not purchased VRI equipment, do not maintain it, or place it in storage rooms where staff cannot find it during emergencies. The cost of a VRI subscription is roughly $3-5 per minute — trivial compared to the cost of a malpractice lawsuit — but hospital administrators treat accessibility spending as overhead rather than patient safety infrastructure. Meanwhile, the Department of Justice has taken enforcement action: in December 2024, DOJ found that Arizona's Department of Child Safety violated Title II of the ADA by failing to provide interpreters for deaf parents and children, demonstrating that this is an ongoing, systemic failure, not an isolated incident.

Real-ear measurement (REM) is the gold standard for verifying that a hearing aid is delivering the correct amplification for a specific patient's ear canal. A tiny probe microphone is placed in the ear canal alongside the hearing aid to measure what the patient is actually receiving versus what they need. The American Academy of Audiology recommends REM for every fitting. Yet surveys consistently show that only 30-34% of audiologists in the United States actually perform it. The remaining 66-70% fit hearing aids using manufacturer default settings, or adjust based on the patient's subjective report of 'does that sound OK?' This matters because every ear canal is different in length, volume, and resonance. A hearing aid programmed to manufacturer defaults can over-amplify or under-amplify by 10-15 dB at certain frequencies. Patients who receive REM-verified fittings experience up to 65% better speech understanding outcomes compared to those fitted with defaults alone. Without REM, a patient may leave the office with a $5,000 pair of hearing aids that makes speech muddy in restaurants, amplifies background noise painfully, or fails to make soft consonants audible. The patient blames the hearing aid — or blames themselves — and 25% of hearing aids end up in a drawer, never worn. This is a $1,175 average waste per abandoned device, multiplied across millions of fittings. The structural reason this persists is threefold. First, REM adds 15-20 minutes to a fitting appointment, and audiologists in high-volume practices or retail chains are under pressure to see more patients per day. Second, not all audiology doctoral programs provide comprehensive REM training, so some audiologists graduate without confidence in the technique. Third, there is no enforcement mechanism — no state licensing board audits whether REM was performed, no insurance company requires it as a condition of reimbursement, and no manufacturer withholds warranty coverage if fitting verification is skipped. The patient has no way to know they received a suboptimal fitting until they struggle in real-world listening situations and assume hearing aids 'just don't work for them.'

Original Medicare — the federal health insurance covering 67 million Americans over 65 — categorically excludes hearing aids and hearing aid fitting exams. This exclusion dates back to 1965 when Medicare was created, and unlike vision or dental, Congress has never amended it. The average cost of a pair of prescription hearing aids in the U.S. is $4,672, with premium devices exceeding $8,000. Seniors on Original Medicare pay 100% of this cost themselves. This matters because age-related hearing loss affects roughly two-thirds of adults over 70, which means the population most likely to need hearing aids is the exact population whose primary insurance refuses to cover them. A Government Accountability Office analysis found that 17% of Medicare beneficiaries cannot afford hearing aids costing $500 or more. These seniors simply go without. They stop attending family gatherings because they cannot follow conversations. They miss medication instructions from doctors. They withdraw socially, which accelerates cognitive decline — the 2024 Lancet Commission identified untreated hearing loss as the single largest modifiable risk factor for dementia. The structural reason this persists is legislative inertia combined with lobbying dynamics. The Medicare Hearing Aid Coverage Act (H.R. 500) was reintroduced in the 119th Congress in 2025 but has stalled repeatedly in prior sessions. CBO scores the cost as significant because of the sheer volume of beneficiaries, and there is no powerful constituency pushing back against the exclusion the way hospital or physician lobbies push back against payment cuts. Meanwhile, Medicare Advantage plans (which cover ~50% of beneficiaries) have quietly added hearing benefits to attract enrollees — 97% of MA plans offered some hearing benefit in 2025 — creating a two-tier system where seniors on Original Medicare are left behind. The OTC hearing aid rule (effective October 2022) was supposed to be the pressure-release valve, but OTC devices are limited to mild-to-moderate hearing loss, lack professional fitting, and have high abandonment rates. For the millions of seniors with moderate-to-severe loss, there is no affordable path. They need prescription devices, professional fitting, and ongoing adjustments — none of which Original Medicare covers.

The childcare subsidy benefits cliff occurs when a small increase in a family's earned income — sometimes as little as $1 per hour or $2,000 per year — pushes them above the eligibility threshold and causes them to lose their entire childcare subsidy at once. A family receiving $12,000/year in childcare assistance that earns $1 too much suddenly owes $12,000/year in full-market-rate childcare costs. The net result of their raise is a massive loss in real disposable income. This is not a theoretical policy concern: it is a concrete calculation that parents make every day when deciding whether to accept a promotion, take on extra hours, or switch to a better-paying job. The economic trap this creates is vicious. Parents who are aware of the cliff rationally refuse raises and promotions to stay below the eligibility line, which keeps them in low-wage jobs indefinitely. Parents who are not aware of the cliff accept a raise, receive a letter saying their subsidy is terminated, and suddenly cannot afford the childcare they have been using — forcing them to pull their child out mid-year, scramble for alternatives, or quit their job to stay home. Either outcome — refusing advancement or losing care — damages the family's long-term economic trajectory. A parent who stays in a $15/hour job for five years to keep their subsidy forfeits tens of thousands of dollars in lifetime earnings growth, retirement savings, and career development. The 2024 CCDF Final Rule attempts to address this by requiring states to cap family copayments at 7% of household income and implement graduated phase-outs, but compliance deadlines extend to August 2026, and states have wide latitude in how they implement the requirement. Even well-designed graduated phase-outs still create a significant effective marginal tax rate on low-income parents' earnings — in some states, the combined effect of losing childcare subsidies, SNAP benefits, Medicaid, and housing assistance as income rises creates an effective marginal tax rate exceeding 80% on the next dollar earned. The childcare cliff is the single largest component of this poverty trap for families with young children, and it will take years of state-by-state implementation to even partially mitigate it.

Fifty-eight percent of rural census tracts in the United States qualify as childcare deserts, meaning there are more than three children under five for every licensed childcare slot. In the most extreme cases, there are zero licensed providers within a reasonable driving distance. When the town of Dubois, Wyoming lost its only licensed childcare provider, the closest alternatives were 75 miles away in Lander or 85 miles away in Jackson — a 150-170 mile round trip through mountain passes that can be impassable in winter. This is not an outlier. Across rural Montana, Missouri, Iowa, and the Adirondack region of New York (where 80% of the area is a childcare desert), families routinely face 20-40 mile drives to the nearest provider, adding 1-2 hours of daily commuting on top of their work commute. The cascading economic damage extends far beyond individual families. Rural employers — hospitals, manufacturing plants, school districts, farms — cannot recruit or retain workers because prospective employees with young children look at the childcare situation and decline job offers. Rural communities that lose childcare providers enter a death spiral: young families leave, the tax base shrinks, schools lose enrollment, and the community becomes even less viable for a childcare business. The Iowa Capital Dispatch reported that childcare gaps in rural America threaten to 'undercut small communities' by removing the basic infrastructure that working-age families need to stay. The structural root cause is population density economics. A childcare center needs a minimum enrollment of 30-50 children to be financially viable, but many rural communities simply do not have enough children within a reasonable radius to support a center. Family childcare homes could fill the gap (they only need 4-8 children), but the 48% decline in licensed family childcare since 2005 has devastated exactly the provider type that rural areas depend on. Federal and state subsidies are structured to support existing providers rather than incentivize new ones to open in underserved areas, and no program adequately compensates for the higher per-child cost of serving a geographically dispersed population.

Starting a new childcare center from scratch requires $100,000 to $500,000 in startup capital, depending on location and size. This includes commercial lease deposits and renovations ($2,000-$10,000/month in rent alone), fire safety and building code compliance (sprinkler systems, commercial kitchen ventilation, egress modifications), furniture and equipment meeting specific safety standards, insurance, and 3-6 months of working capital to cover operating expenses while enrollment ramps up. On top of the financial barrier, the licensing process itself takes 6-12 months in most states: background checks for all staff, facility inspections by fire marshals and health departments, zoning approval from municipal planning boards, and completion of pre-service training requirements that can exceed 40 hours. This means that when demand for childcare surges in a neighborhood — because a new employer moves in, a housing development opens, or an existing provider closes — the market cannot respond for at least a year, and often longer. Childcare supply operates on infrastructure timelines (like building a hospital) while demand operates on life timelines (a baby is born, a parent needs to return to work in 12 weeks). The mismatch between the speed of demand and the speed of supply response is the core mechanism that creates and perpetuates childcare deserts. A community that loses a provider does not get a replacement for 18-24 months at best, and often never, because the economics of childcare make it unattractive to investors compared to almost any other use of the same capital. The structural cause is that childcare is regulated as a commercial enterprise but operates on margins thinner than most restaurants (industry-wide profit margins average around 1-15%, with many providers operating at a loss). No rational investor will put $300K into a business with 1% margins and a 12-month licensing runway when the same capital could earn better returns in almost any other sector. The Small Business Administration and traditional lenders treat childcare centers as high-risk borrowers. Without dedicated public financing mechanisms — construction grants, below-market loans, or guaranteed revenue contracts — the capital barrier ensures that childcare supply will always lag demand, especially in the low-income communities where the need is greatest.

The median hourly wage for childcare workers in the United States is $13.42, producing an annual income of roughly $27,920. This is lower than the median wage for fast food workers and retail employees, whose wages rose 5.2% and 6.8% respectively in recent years while childcare wages grew only 4.6%. Childcare workers are compensated at lower rates than 97% of all professions in the U.S. economy. Thirteen percent of early educators live below the federal poverty line — 5.7 times the rate of elementary school teachers — and 43% of early educator families rely on public safety net programs like Medicaid and food stamps to survive. The direct consequence is not just high turnover (which damages care quality and child development outcomes) but a hard capacity constraint: providers who have physical space and licensing for 80 children can only serve 50 because they cannot hire enough staff to meet state-mandated ratios. In Minnesota, a 2024 survey found over 700 open teaching positions at childcare centers, resulting in more than 2,000 childcare slots sitting empty statewide — not because of lack of demand, not because of lack of facilities, but because there are literally not enough humans willing to do the job at the wages offered. Parents see a center with a 'WAITLIST FULL' sign and assume the building is at capacity. Often, half the classrooms are dark because there is no one to staff them. This persists because childcare is trapped in a cost disease that has no private-market solution. Parents already pay more for childcare than for in-state college tuition in 38 states. Providers cannot raise prices further without losing families. They cannot cut wages further without losing all remaining staff to Target and McDonald's. And taxpayers spend $4.7 billion per year subsidizing early educators' families through safety net programs — essentially paying twice (once for inadequate childcare wages, once for the welfare costs created by those inadequate wages) while getting neither good wages for workers nor sufficient slots for children.

When the American Rescue Plan Act (ARPA) childcare stabilization funds expired — $24 billion on September 30, 2023, with remaining funds expiring September 30, 2024 — states that had eliminated subsidy waitlists during the pandemic were forced to reinstate them. Indiana reimplemented waitlists in December 2024 for new CCDF and On My Way Pre-K voucher applicants, and now has roughly 31,000 children waiting. Virginia's waitlist jumped from approximately 3,000 children in August 2024 to over 14,000 by October 2025. Arizona reinstated its subsidy waitlist on August 1, 2024 — the first time since 2019 — resulting in an average of 5,200 fewer children served each month. A waitlist for a childcare subsidy is not like a waitlist for a restaurant. When a family is placed on a subsidy waitlist, they do not simply wait and then get care. They face months or years with no financial assistance while still needing to work, which means they either pay full market rate (which they cannot afford, because they qualified for subsidies based on income), find informal unregulated care, or leave the workforce. The economic damage compounds: parents lose earnings, employers lose workers, and the state loses tax revenue. The Century Foundation estimated that the expiration of ARPA funding would cause parents to lose $9 billion in annual earnings and states to lose $10.6 billion in economic activity per year. This problem persists because federal childcare funding is structured as temporary emergency relief rather than permanent entitlement spending. ARPA was always time-limited. When it expired, there was no replacement, and state budgets could not absorb the difference. The political dynamic is toxic: Congress passed emergency funding during COVID because 'childcare is infrastructure,' but when the emergency label expired, so did the political will to fund it permanently. States are now citing 'federal uncertainty' as the reason for rolling back services, creating a doom loop where federal inaction causes state cuts, which causes provider closures, which reduces the system's capacity to absorb future funding even if it arrives.

An estimated 43% of children in the United States have at least one parent who works outside the standard 9-to-5 window — evenings, nights, rotating shifts, or weekends. Yet only 8% of center-based childcare providers offer any care before 7 AM or after 6 PM, only 2% offer evening care, 6% offer overnight care, and 3% offer weekend care. The gap between when parents need care and when care is available is not a niche edge case — it affects nearly half of all families with children. This disproportionately hammers low-income families and families of color. Twenty-seven percent of low-income working mothers with children under 12 work a regular evening or night shift or an irregular schedule. These are nurses, warehouse workers, restaurant staff, retail employees, first responders — people whose jobs cannot be done remotely and whose shifts are non-negotiable. When formal care is unavailable, parents must patch together informal arrangements: a rotating cast of relatives, neighbors, and teenage babysitters, none of whom are vetted, trained, or reliable week to week. Some parents bring children to work. Some leave older children to watch younger ones. Some quit their jobs entirely. A parent working a 3 PM-11 PM hospital shift who cannot find evening childcare does not have the option to 'just find a different shift' — healthcare facilities assign shifts based on seniority and staffing needs, not employee preference. The structural barrier is that nonstandard-hours care is even more expensive to provide than daytime care (staff expect premium pay for evenings and weekends, and occupancy rates are lower because demand is spread across more time slots) while the families who need it are disproportionately low-income and unable to pay premium rates. Subsidy programs rarely cover nonstandard hours adequately, and many impose penalties for schedule changes. No business model currently makes evening/weekend childcare financially viable at scale without dedicated public funding that does not exist.

Between 2005 and 2017, the number of licensed small family childcare homes in the U.S. fell by 48%, with over 90,000 small family childcare homes closing. In New York alone, home-based providers accounted for 83.9% of all provider losses and 87.2% of capacity losses between 2019 and 2021. As of 2024, only about 98,000 licensed family childcare programs remain nationwide, down from nearly 200,000 two decades ago. This collapse matters enormously because family childcare homes are the backbone of care in rural areas, serve nonstandard hours more often than centers, and are frequently the only culturally and linguistically matched option for immigrant families. The licensing burden on a solo family childcare provider — someone watching 4-6 children in their home — is disproportionate to their scale. They must pass the same background checks, complete the same training hours, meet building code inspections, maintain specific square footage per child, install commercial-grade safety equipment, and submit to unannounced inspections — all while earning a median income of roughly $25,000-$30,000 per year. Many states require 40+ hours of pre-service training and 15-24 hours of annual continuing education. For a single person running a home-based business with no administrative staff, the paperwork and compliance overhead alone can consume 10-15 hours per week that could otherwise be spent caring for children. The structural reason this persists is that licensing regulations are written for institutional settings and then awkwardly retrofitted for home-based care. Legislators and regulators face asymmetric political risk: if they loosen home-based licensing and a child is harmed, the political consequences are severe. If they maintain burdensome requirements and thousands of providers quietly close, there is no news cycle. The result is a regulatory ratchet that only tightens, steadily eliminating the most affordable, flexible, and community-embedded form of childcare in America.

There is no centralized childcare waitlist system in the vast majority of U.S. markets. Each daycare center, family childcare home, and preschool maintains its own independent waitlist using its own software (or a spreadsheet, or a paper notebook). A pregnant parent who needs infant care must individually research providers, call or visit each one, fill out separate application forms, pay separate waitlist fees ($25-$100 per center in many markets), and then track their position on each list independently. In competitive markets like Seattle, parents report applying to 15-20 programs simultaneously and still not securing a spot before their parental leave ends. This is not just an inconvenience — it is a systemic failure that wastes thousands of hours of parent time, creates information asymmetry (parents have no idea how long each waitlist actually is or how fast it moves), and results in massive inefficiency for providers too. Centers have no visibility into how many families on their waitlist have already found care elsewhere, so they maintain bloated lists of 200+ names when only 30 are still actually looking. When a spot opens, the center calls down the list and reaches voicemail after voicemail from parents who enrolled somewhere else months ago. Meanwhile, a parent who is desperately searching has no idea that a spot just opened three blocks from their house. This problem persists because each childcare provider is a small, independent business with no incentive to share waitlist data with competitors. Software vendors like Kiddo and WaitListPlus sell waitlist tools to individual centers, not to communities. The few attempts at regional coordination (like OneHSN) have limited adoption because providers see no benefit in transparency — a long waitlist is actually a marketing asset that signals demand. The result is a tragedy of the commons where every individual actor behaves rationally but the system as a whole fails parents.

The Child Care and Development Fund (CCDF) is the primary federal program that helps low-income families pay for childcare through vouchers. But states set reimbursement rates based on market rate surveys that are often years out of date, and the rates they set systematically underpay providers. In Texas, monthly reimbursement rates for the highest-rated center-based infant care fall short of the true cost of care by $327 to $870 per child per month. In Massachusetts, only 56.1% of childcare providers participate in the subsidy system at all, because reimbursements cover roughly 33-38% of actual costs. The downstream effect is devastating for the families these subsidies are supposed to help. A parent receives a voucher that says 'the government will pay for your childcare,' but when they call providers, center after center says 'we don't accept vouchers.' The parent is technically eligible for subsidized care but functionally locked out of it. This is not a hypothetical: only 15% of children eligible for CCDF subsidies actually receive them. The gap between eligibility and receipt is not primarily a paperwork problem — it is a supply problem created by rates so low that providers lose money on every subsidized child they enroll. This problem persists because the political incentive is to maximize the number of families 'eligible' for subsidies (which looks good in press releases) rather than to set reimbursement rates high enough that providers actually accept them (which costs more money per family served). The 2024 CCDF Final Rule requires states to use cost modeling rather than outdated market rate surveys, but compliance deadlines stretch to 2026-2028, and even cost-modeled rates may be set below true costs if state budgets are tight. Meanwhile, Arkansas cut School Readiness reimbursement rates in 2025 with no warning, and providers immediately threatened to stop accepting subsidized children.

State licensing laws require one caregiver for every three or four infants (depending on the state), compared to 1:10 or higher for preschool-age children. This means a single infant classroom of 8 babies requires two or three dedicated staff members, while the same two or three staff could serve 20-30 four-year-olds. The economics are brutal: the average cost of center-based infant care in the U.S. is $1,230/month per child, yet providers still barely break even on infant rooms because labor costs consume 70-80% of revenue and ratio requirements cap how many children each worker can serve. This matters because infant care is exactly the period when parents most need to return to work. Parental leave in the U.S. averages 8-12 weeks, but infant waitlists routinely stretch 6-18 months. Parents who cannot find infant care face an impossible choice: quit their job, cobble together informal arrangements with unvetted caregivers, or delay returning to work and burn through savings. One parent in Kansas reported that the closest daycare with infant openings was 20 miles away with no spots available, meaning even if a slot opened, it would add two hours of daily driving. Nationally, 34 of Oregon's 36 counties are classified as childcare deserts specifically for infants and toddlers, while only 9 of 36 are deserts for preschoolers. The problem persists structurally because ratio requirements are set by state licensing boards that (correctly) prioritize safety for the most vulnerable age group, but no mechanism exists to subsidize the higher per-child cost that ratios create. The result is a market where providers rationally minimize infant slots to maximize revenue per staff member, and the children who need care most are the ones least likely to get it. Kansas alone is 80,000 childcare spots short of demand, and the shortfall is overwhelmingly concentrated in the infant and toddler age brackets.

The Atacama Salt Flat in northern Chile sits in one of the driest environments on Earth, receiving less than 15 millimeters of rainfall per year. Beneath it lies a lithium-rich brine that SQM and Albemarle pump to the surface and evaporate in massive ponds. This process consumes an estimated 500,000 gallons of water per ton of lithium produced. The pumping rate exceeds the natural aquifer recharge rate, and satellite measurements show the salt flat is subsiding by up to 2 centimeters per year. The water table is dropping, freshwater lagoons that support flamingo populations and endemic microbial ecosystems are shrinking, and the aquifer system that indigenous Atacameno communities depend on for drinking water and agriculture is being depleted. By 2025, lithium mining in South America threatens water supplies for over 1.5 million local residents across the 'lithium triangle' spanning Chile, Argentina, and Bolivia. In Chile specifically, 65% of lithium operations risk affecting local agriculture through groundwater depletion. The Atacameno communities have filed legal challenges arguing that their water rights and ancestral territories are being sacrificed for a mineral that powers electric vehicles in wealthy countries. The irony is not lost on anyone: the 'green transition' mineral is being extracted in a way that creates an environmental and human rights crisis in the communities where it is mined. Direct lithium extraction (DLE) technologies promise to reduce water consumption by reinjecting brine after lithium is removed, rather than evaporating it. But DLE remains largely unproven at commercial scale. A Nature Reviews Earth & Environment study found that the environmental claims of DLE companies have not been independently verified, and the technology's water footprint depends heavily on the specific chemistry and geology of each brine deposit. Companies like SQM have announced DLE pilots, but these are years away from replacing conventional evaporation ponds at full production scale. This problem persists because Chile's water governance framework treats groundwater and brine as separate legal resources, even though they are hydrologically connected. Mining companies hold brine extraction rights that do not account for the impact on adjacent freshwater aquifers. The economic incentive is overwhelming: Chile produces roughly one-quarter of the world's lithium, and the government collects substantial royalties. Reforming water rights to reflect hydrological reality would restrict production and reduce revenue, creating a political economy that favors the status quo even as the aquifer declines.

On February 18, 2025, a tailings dam at Sino Metal Leach Limited, a Chinese-owned copper mine near Kitwe in Zambia's Copperbelt Province, collapsed and discharged approximately 50 million liters of acidic water laden with heavy metals into the Chambishi stream, a tributary of the Kafue River. The contamination forced the shutdown of public water distribution, leaving 700,000 people in Kitwe without potable water. Days later, a second tailings dam failure was discovered at the nearby Rong Xin Limited mine, compounding the contamination. Fish died en masse, farmers lost crops, livestock perished, and communities downstream suffered skin and diarrheal diseases from contact with contaminated water. In March 2025, a tailings dam called Laguna Kenko failed in Bolivia's Llallagua District, killing two people and destroying 47 houses. These are not isolated events. The global rate of tailings dam failures has not decreased despite decades of engineering knowledge about their risks. A March 2026 EPA working paper documented the ongoing correlation between tailings dam failures and natural hazards in the US, while climate change is making the triggers (intense storms, drought-flood cycles) more frequent and severe. The most alarming aspect is the information gap. There is no comprehensive global database of tailings dams, their condition, their contents, or their risk profiles. The standard of public reporting on tailings dam incidents is poor, with many failures going completely unreported or lacking basic facts when reported. After the 2019 Brumadinho disaster in Brazil killed 270 people, the industry launched the Global Industry Standard on Tailings Management (GISTM), but adoption is voluntary and verification is inconsistent. Mining companies self-report dam conditions with no independent audit requirement in most jurisdictions. This problem persists because tailings dams are orphan infrastructure. They generate no revenue; they are pure cost centers for mining companies. Incentives favor building new dams cheaply over maintaining existing ones robustly. Many tailings dams were constructed decades ago to older engineering standards and have been expanded incrementally without comprehensive stability reassessment. When mines close, the dams remain as permanent liabilities that require perpetual monitoring and maintenance, but the companies that built them may no longer exist.

On March 16, 2026, the US Forest Service transferred 2,422 acres of Oak Flat (Chi'chil Bildagoteel) in Arizona to Resolution Copper, a joint venture of Rio Tinto and BHP. The site is sacred to the San Carlos Apache Tribe, who have used it for religious ceremonies, burials, and coming-of-age rituals for centuries. Resolution Copper plans to extract 20 million tons of copper via block-cave mining, a technique that will eventually create a crater more than 1,000 feet deep and up to two miles across, permanently destroying the surface landscape and the religious practices that depend on it. The transfer was authorized by a provision inserted into the 2015 National Defense Authorization Act, a defense spending bill, bypassing the normal public lands process. Oak Flat had been protected from mining since 1955 under an executive order signed by President Eisenhower. Trump's March 2025 executive order fast-tracking domestic mining projects placed Oak Flat on a priority list alongside eight other mining projects. The 9th Circuit Court of Appeals denied an injunction three days before the transfer, and the Supreme Court rejected the Apache plea 6-2. The copper under Oak Flat is valued at approximately $200 billion at current prices and could supply up to one-quarter of US copper demand for 40 years. This economic calculus drove the decision, but the precedent it sets extends far beyond one mine. The case established that the Religious Freedom Restoration Act does not protect indigenous sacred sites on federal land from being transferred to private mining companies through legislative riders. Apache women filed an emergency Supreme Court petition in March 2026 to prevent the transfer; it was denied. This problem persists because indigenous sacred sites on federal land have no affirmative statutory protection comparable to the National Historic Preservation Act's treatment of archaeological sites. The legal framework treats religious freedom as a negative right (the government cannot prohibit practice) rather than a positive right (the government must preserve the conditions that make practice possible). When the land itself is the church, transferring the land to a mining company destroys the church, but courts have held this does not constitute a 'substantial burden' on religious exercise under existing law.

In 2022, there were approximately 600 mining engineering students enrolled across all US universities, down from 1,500 in 2015, a 39% decline. The number of accredited mining engineering programs has fallen from 25 in 1982 to 15 in 2023. Canada has seen a one-third drop in mining engineering graduates since 2016. Australia's mining engineering enrollment has collapsed by 63% since 2014. This is happening at the exact moment when the industry faces its largest workforce crisis in decades. The Mining Association of America projects the US mining sector needs 27,000 skilled workers within five years. A more conservative estimate puts the gap at 24,000 new workers needed by 2026, against only 16,000 expected to be available. The demand is not speculative: more than half of the US mining workforce, approximately 221,000 workers, is expected to retire by 2029. These are experienced geologists, mine planners, ventilation engineers, heavy equipment operators, and safety professionals whose knowledge cannot be replaced by hiring recent graduates who do not exist. The consequences are concrete. Critical mineral projects that receive federal fast-tracking and billions in DoD investment cannot operate without qualified engineers and geoscientists to design, permit, and manage them. MP Materials, Lithium Americas, USA Rare Earth, and dozens of other companies competing for a limited pool of mining professionals are bidding up salaries, poaching from each other, and still cannot fill positions. The workforce shortage is becoming the binding constraint on domestic critical mineral production, more limiting than permitting or capital. The pipeline problem persists because mining carries deep reputational baggage among young people. Students perceive the industry as dangerous, environmentally destructive, and located in remote areas far from urban centers. University mining departments struggle to attract faculty because industry salaries vastly exceed academic pay. The Mining Schools Act of 2023 authorized $10 million per year in grants for recruitment, but the funding is modest relative to the scale of the deficit, and rebuilding a generation of mining expertise takes a decade even under the best circumstances.

An estimated 500,000 abandoned hardrock mines exist across the United States, remnants of gold, silver, copper, and other metal mining operations dating back to the 19th century. At least 23,000 of these are in Colorado alone, where more than 500 measurably contaminate water quality. These mines continuously discharge acid mine drainage laden with arsenic, cadmium, lead, zinc, and other heavy metals into rivers and streams. The contamination is perpetual: the chemical reactions that produce acid drainage occur spontaneously when sulfide minerals are exposed to air and water, and they will continue for centuries without intervention. For decades, the cleanup of these sites was blocked by a legal paradox. Under the Clean Water Act and the Comprehensive Environmental Response, Compensation, and Liability Act (Superfund), anyone who touches a contaminated site can become liable for the full cost of remediation, even if they had nothing to do with the original pollution. This meant that environmental groups, state agencies, and good-faith volunteers who attempted partial cleanups risked being sued for the entire remaining contamination. The result was that nobody touched the sites, and the pollution continued unchecked. The Good Samaritan Remediation of Abandoned Hardrock Mines Act, signed in December 2024, created an EPA pilot program that shields cleanup volunteers from Superfund and Clean Water Act liability. But the program authorizes only 15 permits over seven years, covering a tiny fraction of the 500,000 sites. Meanwhile, an estimated 98% of abandoned mines do not qualify for Superfund cleanups due to capacity and financial constraints. The scale of the problem dwarfs the available tools. The problem persists because the mines predate modern environmental law. The original operators are long dead or dissolved, and there is no responsible party to pursue. Federal land management agencies (BLM, Forest Service) manage land containing thousands of these sites but lack dedicated funding for remediation. The 2024 law is a step, but at 15 sites over seven years, it would take over 2,300 years to address all 500,000 abandoned mines at that pace.

Federal law requires coal mining companies to post reclamation bonds guaranteeing they will restore mined land to its approximate original contour and use. In practice, these bonds are systematically set too low. A 2021 analysis of outstanding reclamation needs at modern surface coal mines in the eastern US found 633,000 acres requiring cleanup at an estimated cost of $7.5 to $9.8 billion. The bonds available for that cleanup totaled $3.8 billion, leaving a gap of $3.7 to $6.2 billion. Tennessee alone reported bonds $27 million short of its reclamation needs in its 2025 primacy report. The gap is not static; it widens every time a coal company goes bankrupt. Since 2012, a wave of coal company bankruptcies across Appalachia has allowed operators to shed reclamation obligations through Chapter 11 proceedings. When a company declares bankruptcy, its mining permits and associated bonds transfer to successor entities or, in the worst case, the bond is forfeited and the state inherits an unfunded cleanup obligation. Over half of the coal mined in central Appalachia now comes from companies that have been through bankruptcy, meaning the operators who created the disturbance are legally divorced from the obligation to fix it. The consequences fall on specific communities. Unreclaimed mine sites leach acid mine drainage into streams, destabilize hillsides above homes, and leave landscapes that cannot support economic alternatives. In West Virginia, Virginia, and Kentucky, towns surrounded by unreclaimed mines cannot attract investment, tourism, or even basic infrastructure maintenance because the environmental liability is unresolved and the responsible party no longer exists. This problem persists because bond amounts are set by state regulators who face political pressure from the coal industry, and because federal oversight through the Office of Surface Mining Reclamation and Enforcement has been inconsistent. Self-bonding, which allows companies to guarantee their own cleanup based on financial strength rather than posting cash or surety bonds, has been especially problematic: when a self-bonded company goes bankrupt, there is literally no money backing the reclamation promise. The Surface Mining Control and Reclamation Act of 1977 created the framework, but 48 years later, its enforcement mechanisms have not kept pace with the financial fragility of the industry it regulates.

On January 28, 2026, a landslide triggered the collapse of artisanal mining tunnels at Rubaya in eastern Democratic Republic of the Congo, killing over 400 people. Six weeks later, on March 3, 2026, a second landslide at the same site killed over 200 more. The victims were overwhelmingly artisanal miners, but also children, small traders, and residents of surrounding villages. Many died of asphyxiation underground; others were crushed by collapsing earth. The mines reopened by February 2, less than a week after the first disaster, with miners returning to the same unstable tunnels. Rubaya produces between 15 and 30 percent of the world's coltan, the ore from which tantalum is extracted for use in capacitors found in every smartphone, laptop, and server on earth. The site has been classified as 'red status' by the DRC government, meaning all mining and mineral commercialization is officially prohibited. Yet mining continues in flagrant violation of this designation because the M23 rebel group, which has controlled the area since May 2024, imposes taxes on coltan extraction amounting to over $800,000 per month. The armed group has no incentive to enforce safety standards and every incentive to maximize extraction. The structural geology of Rubaya makes artisanal mining especially lethal. Miners dig narrow shafts and tunnels manually using basic tools, creating complex branching networks that extend into hillsides. Over time, these excavations create honeycomb-like voids that weaken slope integrity. When heavy rains saturate the destabilized ground, the hillsides fail catastrophically. There is no engineering support, no ventilation, no escape infrastructure, and no rescue capability. This problem persists because of a toxic intersection of armed conflict, global supply chain opacity, and poverty. The miners at Rubaya have no alternative livelihood. Over 73% of the DRC's population lives below the international poverty line. International supply chain due diligence frameworks like the OECD guidelines and the EU Conflict Minerals Regulation exist on paper, but they cannot enforce safety standards at a site controlled by a rebel militia in an active conflict zone. The coltan enters the global supply chain through intermediaries, gets smelted, and becomes untraceable tantalum powder in components that end up in devices sold by companies that have pledged responsible sourcing.

Lithium Americas' Thacker Pass mine in Humboldt County, Nevada is designed to be the largest lithium mine in North America, producing enough lithium carbonate to supply batteries for roughly 800,000 electric vehicles per year. But in June 2025, the Nevada State Engineer ordered the mine to cease unauthorized water pumping after rancher Edward Bartell demonstrated that the mine's water use was depleting the aquifer his cattle operation has depended on since 2008 under senior water rights. The water conflict forced a legal and commercial reckoning. Bartell's senior water rights predate the mine's permits, and under Nevada's prior appropriation doctrine, his claim takes priority regardless of the mine's economic importance. The resulting lawsuits, appeals, and cease-and-desist orders pushed the mine's full-capacity production target from 2026 to 2028. At peak construction, 1,800 workers were expected on-site by summer 2026, and the delay cascades through the entire domestic lithium supply chain at a moment when the US is trying to reduce dependence on Chinese-processed lithium. The dispute was eventually settled when Lithium Americas purchased Bartell's water rights directly, but the resolution highlights a structural problem: hard-rock and clay lithium extraction in the arid American West competes directly with agricultural water users who hold legally superior claims. This is not unique to Thacker Pass. Every proposed lithium project in Nevada's basins faces the same prior appropriation framework, and ranchers and tribal nations in those basins have water rights that predate any mining permit. The problem persists because western water law was designed for a world where mining and agriculture were the only competing users, and both were assumed to have adequate supply. Climate change has reduced recharge rates in Nevada's hydrographic basins, making the zero-sum competition between lithium extraction and existing water rights holders sharper. There is no federal mechanism to adjudicate these conflicts efficiently; they play out mine-by-mine, basin-by-basin, through state engineer offices and courts that were not designed to handle the volume or urgency of critical mineral permitting.

The United States can mine rare earth ore. MP Materials at Mountain Pass, California produced over 45,000 metric tons of rare earth oxide concentrate in 2024. But mining is not the bottleneck. The bottleneck is the mid-stream processing: separating mixed rare earth concentrates into individual oxides, reducing those oxides to metals, alloying them, and sintering them into finished neodymium-iron-boron (NdFeB) permanent magnets. In 2024, the US had one operational refinery producing approximately 1,300 metric tons of neodymium-praseodymium (NdPr) metal alloy. China produced between 240,000 and 260,000 metric tons of finished NdFeB magnets in the same period. This ratio means the US defense industrial base, EV supply chain, and wind turbine manufacturing are structurally dependent on a single foreign country for components that go into F-35 fighter jets, guided missiles, electric vehicle motors, and offshore wind generators. When China imposed export licensing controls on seven rare earth elements in April 2025, and then expanded controls to cover processing equipment and magnet assemblies containing Chinese-sourced materials in October 2025, the dependency became an active vulnerability rather than a theoretical one. The Department of Defense invested $400 million in MP Materials in July 2025, and MP's Independence facility in Texas has begun trial production of automotive-grade magnets. But the planned 10X facility at Northlake, Texas will not reach its 7,000 metric ton annual capacity until 2027-2028. Heavy rare earth separation at Mountain Pass is slated to commission in mid-2026. These timelines leave a multi-year window where the US has no domestic buffer against Chinese export throttling, which Beijing can tighten selectively by end-use category rather than total quantity. This gap persists because rare earth separation chemistry is extraordinarily difficult. The elements differ by fractions of an angstrom in ionic radius, making physical separation nearly impossible. Solvent extraction requires hundreds of mixer-settler stages, billions in capital, years of permitting, and deep process expertise that the US effectively offshored to China over three decades. Rebuilding this capability is not a matter of political will alone; it requires training chemists and metallurgists in processes that no US university has taught at scale since the 1990s.

In April 2024, the Mine Safety and Health Administration finalized a rule lowering the permissible exposure limit for respirable crystalline silica in mines to 50 micrograms per cubic meter, down from the previous 100 micrograms for coal mines. The rule was projected to prevent over 1,000 deaths and 3,700 cases of silica-related illness. But a federal court stay in April 2025, followed by two successive enforcement postponements by the Trump administration, has left coal miners with no updated protection. MSHA announced in November 2025 that it would 'reconsider' the rule entirely, signaling a likely rollback. This matters because black lung disease is not a historical artifact. It is surging. In central Appalachia, the disease now affects one in five miners with 25 years of experience, rates not seen since the 1970s. The driver is not coal dust alone but silica: as coal seams thin out, miners cut through more surrounding rock, and mine dust can be 50% silica compared to 1% when mining pure coal. Silica causes progressive massive fibrosis, an aggressive and incurable form of black lung that kills younger miners faster than the traditional disease ever did. The human cost is not abstract. These are miners in their 40s and 50s in West Virginia, Virginia, and Kentucky who cannot breathe, who require lung transplants, and whose families lose their breadwinner. The National Black Lung Association unveiled a 2026 policy platform in March specifically because the regulatory vacuum is creating a new generation of preventable deaths. Every month the rule stays frozen, miners inhale dust at levels the government's own scientists say are lethal over time. This problem persists because of a structural conflict: coal operators argue compliance costs are too high and sued to block enforcement, while the miners who bear the health consequences have no comparable legal or lobbying power. The result is a regulatory feedback loop where rules get finalized, challenged, delayed, reconsidered, and diluted across administrations, while the disease progresses in miners' lungs on a biological timeline that does not wait for rulemaking cycles.

A patient hands their insurance card to the pharmacist and pays a $15 copay for generic amoxicillin. The actual cash price of that amoxicillin is $4. The PBM keeps the $11 difference through a mechanism called a copay clawback. Research from USC Schaeffer Center found that 23% of commercially insured prescription fills involve a copay that exceeds the drug's total cost to the insurer. Among these overpayment claims, the average overpayment is $7.69. Across the insured population, this adds up to billions of dollars in unnecessary patient spending on drugs that would be cheaper if patients simply paid cash and skipped their insurance entirely. The patient has no way to know this is happening. The pharmacy's computer system shows a copay amount set by the PBM, and the patient assumes their insurance is covering the rest. In reality, the insurance is covering nothing -- the PBM is extracting a surcharge from the patient above the drug's actual cost. Congress banned explicit gag clauses in 2018, meaning PBMs can no longer contractually prohibit pharmacists from telling patients about cheaper cash prices. But the cultural and operational legacy of gag clauses persists. Most pharmacy software systems do not flag when a copay exceeds the cash price. Pharmacists filling 300+ prescriptions per day do not have time to check cash prices against copays for every transaction. And pharmacists who proactively steer patients away from using insurance risk retaliation from PBMs, who track prescription volume and can terminate pharmacies from their networks for pattern deviations. The problem is structural because PBMs profit directly from the spread between what they charge patients (the copay) and what they pay pharmacies (the reimbursement). Eliminating copay clawbacks would eliminate a revenue stream. While federal law now prohibits gag clauses, there is no requirement for PBMs to set copays at or below the cash price, no requirement for pharmacy systems to alert pharmacists to overpayment situations, and no penalty for PBMs that continue to extract clawbacks. The information asymmetry is by design: the PBM knows the cash price, the reimbursement rate, and the copay, but the patient sees only the copay. Texas passed SB 493 in 2025 to further strengthen gag clause prohibitions, but the fundamental economic incentive for PBMs to charge patients more than drugs cost remains untouched.

Independent pharmacies cannot negotiate directly with PBMs for network inclusion and reimbursement rates. Instead, they join Pharmacy Services Administrative Organizations (PSAOs), which negotiate PBM contracts on behalf of groups of pharmacies. The five largest PSAOs are now owned by pharmaceutical wholesalers -- the same companies that sell the pharmacies their drug inventory. After signing a PSAO agreement, the pharmacy is obligated to contracts that the PSAO signs on its behalf, but the pharmacy often cannot see the terms of those contracts or even know they exist. Reimbursement rates, GER benchmarks, audit provisions, and network requirements are all set in contracts the pharmacy owner has never read. The auto-acceptance mechanism is particularly predatory. PBMs send contract amendments to pharmacies via fax. If the pharmacy does not respond within a specified window -- typically one to two weeks -- the contract is deemed accepted. Since contracts arrive by fax, they can be lost, buried in junk faxes, or arrive when the pharmacist is focused on filling 300 prescriptions per day. A missed fax can bind the pharmacy to below-cost reimbursement rates for an entire contract year. The pharmacy owner discovers the new terms only when reimbursement checks start arriving smaller than expected, by which point there is no mechanism to renegotiate. This is not a hypothetical edge case -- pharmacy advocacy groups report it as a widespread, systemic practice. The structural root cause is market concentration and vertical integration. The three largest PBMs control 80% of the market, so they set terms unilaterally. PSAOs were originally created to give independent pharmacies collective bargaining power, but wholesaler acquisition of PSAOs converted them from pharmacy advocates into supply-chain intermediaries with divided loyalties. The wholesaler-owned PSAO has financial incentives to maintain its relationship with PBMs (which drive prescription volume) even at the expense of the pharmacies it ostensibly represents. CMS proposed changes to Part D contracting rules in 2025 that would address some of these issues, but PBMs lobbied aggressively against them, and pharmacies and PBMs remain fundamentally at odds over whether pharmacies should have any meaningful say in the terms that govern their reimbursement.

PBMs conduct audits of pharmacy claims and demand recoupment for any discrepancy found. In 2025, these audits became dramatically more aggressive. According to pharmacy law firm Buchanan Ingersoll & Rooney, PBMs increased the number of audits conducted, expanded the scope of what they examine, and began enforcing technical documentation standards with unprecedented rigidity. Documentation that was historically accepted -- minor variances in quantity notation, timestamps, or refill authorization formats -- is now being rejected. PBMs have also begun citing audit findings from one or two years ago as evidence of a broader pattern of non-compliance, using old findings to justify new recoupment demands. For an independent pharmacy filling 200-300 prescriptions per day, even a 1-2% discrepancy rate can generate five-figure recoupment demands. The pharmacy cannot effectively dispute findings because PBM contracts give the PBM unilateral authority to determine what constitutes a discrepancy. State pharmacy fair audit laws were supposed to protect pharmacies: they limit how far back PBMs can review claims, prohibit extrapolation (using a sample of claims to calculate recoupment across all claims), and require PBMs to provide detailed findings before demanding payment. But pharmacies regularly report that PBMs conduct extrapolation audits despite clear state prohibitions, and enforcement of these laws is essentially nonexistent. A pharmacy that refuses to pay a recoupment demand risks being terminated from the PBM network, which would cut off access to the majority of its patients' insurance plans -- a business death sentence. The structural problem is that PBM audits are not primarily about compliance -- they are a profit center. The PBM has already been paid by the health plan for the prescription. When it claws back payment from the pharmacy, the PBM keeps the difference. There is no requirement for the PBM to return recouped funds to the health plan or the patient. This creates a perverse incentive: the more aggressively the PBM audits, and the more technical the standards it enforces, the more money it extracts from pharmacies. The pharmacy's only recourse is expensive litigation, which most independent owners cannot afford. PBMs know this, and they calibrate their recoupment demands accordingly -- large enough to be profitable, small enough that litigation costs more than paying.

Pharmaceutical manufacturers offer copay assistance cards for expensive specialty drugs -- a patient taking a biologic for rheumatoid arthritis that costs $6,000/month might pay only $5/month with the card. Historically, these copay card payments counted toward the patient's annual deductible and out-of-pocket maximum, meaning the manufacturer was effectively paying down the patient's cost-sharing obligation. Copay accumulator programs change this: the insurer accepts the manufacturer's copay card payment but does not apply it toward the patient's deductible or out-of-pocket maximum. As of 2025, 84% of commercially insured beneficiaries are enrolled in plans where copay accumulators are available in the plan design. The patient experience is devastating and deliberately opaque. For the first few months of the year, the copay card covers the patient's cost, and everything seems fine. Then the copay card funds are exhausted -- typically by month 4 or 5 -- and the patient suddenly owes the full cost-sharing amount because none of the previous payments counted toward their deductible. A patient on a $6,000/month biologic who thought they were paying $5/month is suddenly billed $2,000 or more in a single month. Many patients cannot pay. They stop taking their medication. For patients with conditions like multiple sclerosis, Crohn's disease, or organ transplant rejection, stopping medication mid-course can cause irreversible disease progression, organ damage, or death. The patient often does not understand why their costs suddenly spiked -- the accumulator program is buried in plan documents that no one reads. This problem persists because copay accumulators are enormously profitable for insurers and PBMs. The manufacturer's copay card pays the insurer for the drug, but the insurer does not credit the patient's deductible, so the insurer collects twice: once from the manufacturer and once from the patient (or avoids paying when the patient abandons treatment). As of March 2025, only 21 states have banned copay accumulators for state-regulated health plans, and these bans do not apply to self-funded employer plans (which cover the majority of commercially insured workers) because of ERISA preemption. The 2025 Notice of Benefit and Payment Parameters rule prohibited copay maximizers but offered no guidance on accumulators, leaving the core problem unaddressed.

Pharmacy technicians are the backbone of prescription dispensing operations. They enter prescriptions into the system, count and package medications, manage inventory, handle insurance billing, assist with compounding, and increasingly administer vaccines. They work with controlled substances that require DEA-regulated handling. They are often the first line of defense for catching potential dispensing errors before the pharmacist's final verification. For this, they earn a mean hourly wage of $20.83 -- less than many retail cashier and fast food positions that carry none of these responsibilities. The result: 88% of pharmacies and 74% of hospitals report technician shortages, with annual turnover rates of 21-30%. The turnover creates a vicious cycle that directly endangers patients. When a technician leaves, the remaining staff must absorb their workload. The pharmacist, already verifying hundreds of prescriptions per day, loses the technician support that allows them to focus on clinical review rather than counting pills. New technicians take months to train to competency, and during that period, error rates increase. Pharmacies that cannot fill technician positions reduce operating hours, turn away patients, or close entirely. Hospital pharmacies that cannot staff their IV rooms face delays in preparing chemotherapy, antibiotics, and pain medications for inpatients. The shortage feeds the staffing crisis for pharmacists too: when technicians quit, pharmacists burn out faster, and then pharmacists quit. The wage problem persists because pharmacy reimbursement is set by PBMs, not by pharmacies. An independent pharmacy owner who wants to pay technicians $25/hour to reduce turnover cannot simply raise prices -- PBM contracts dictate what they receive per prescription. The margin per prescription has been declining for over a decade, which means labor budgets shrink even as workload increases (more vaccines, more clinical services, more insurance phone calls). Chain pharmacies set technician wages at corporate headquarters based on regional labor market data, not on the clinical complexity of the work. Until pharmacy technician compensation reflects the actual skill, risk, and responsibility of the role, the shortage will continue, and patients will bear the consequences of an understaffed system.

In 2024 alone, 2,800 pharmacies in the United States closed. Walgreens announced plans to close 500 locations in 2025 and another 700 over the following two years. Rite Aid, after a second bankruptcy filing, has ceased operations entirely. The result: 48.4 million people -- one in seven Americans -- now live in a pharmacy desert, defined as an area more than 10 miles from the nearest pharmacy. Another 9% of Americans have access to only a single pharmacy, meaning one more closure eliminates their access completely. In Mendocino County, California, when Genoa Healthcare closed its Gualala location in November 2025, it was the sole pharmacy along a 60-mile stretch of coast. Residents now drive over 90 minutes round-trip to fill prescriptions. For elderly patients who no longer drive, for patients without reliable transportation, for patients on daily medications like insulin or blood thinners that cannot wait for a mail-order delivery delay, this is not an inconvenience -- it is a medical emergency in slow motion. Pharmacy deserts are not randomly distributed. They concentrate in rural areas, low-income urban neighborhoods, and communities of color -- the same populations with the highest chronic disease burden and the greatest need for medication access. The closures are driven by a business model that has become structurally unprofitable. PBM reimbursement rates for generic drugs are often below the pharmacy's acquisition cost. DIR fees and GER clawbacks eat remaining margins retroactively. Front-end retail sales that once subsidized pharmacy operations have shifted to Amazon and dollar stores. Meanwhile, pharmacies cannot raise prices because PBMs set the reimbursement rates unilaterally. The Consolidated Appropriations Act of 2026 included funding for investigations of pharmacy reimbursement complaints, and the Rural Health Transformation program allocated $50 billion over five years for rural healthcare, but neither addresses the fundamental economics: as long as PBMs can reimburse pharmacies below cost, closures will continue, and the distance between patients and their medications will keep growing.

When a patient arrives at a pharmacy with a prescription that requires prior authorization, the pharmacist cannot dispense the medication. The patient leaves empty-handed. The pharmacy must contact the prescribing physician, who must then submit clinical justification to the insurer or PBM, who reviews it on their own timeline. A Surescripts survey found that 87% of pharmacists and 89% of prescribers say prior authorization requirements negatively impact patient health outcomes. More than a quarter of patients waited two weeks to over a month for a decision. Nearly half of pharmacists reported that the process often leads patients to abandon treatment altogether. The human cost is not abstract. A diabetic patient whose insulin requires PA because their insurer changed formularies mid-year goes without insulin for days or weeks. A patient with a bacterial infection whose antibiotic requires PA because the prescriber chose a non-preferred agent does not get to pause their infection while paperwork processes. A psychiatric patient whose antidepressant requires step therapy -- proving they failed on a cheaper drug first -- goes through weeks of medication changes that destabilize their condition. In each case, the PA process assumes that delaying treatment is medically neutral. It is not. Delayed treatment leads to emergency department visits, hospitalizations, and in documented cases, death. Prior authorization persists because it saves insurers money by creating friction. Every patient who abandons treatment is a cost the insurer does not bear. Every physician who switches to a cheaper formulary drug to avoid the PA hassle saves the insurer the price difference. The system is designed to produce exactly these outcomes. In June 2025, major insurers including CVS/Aetna, UnitedHealthcare, and Cigna agreed to provide real-time responses for at least 80% of PAs, but this is a voluntary commitment with no enforcement mechanism, and it does not address the fundamental problem: the decision about whether a patient receives their prescribed medication is made by an entity whose financial interest is served by denying or delaying it.